A human study to evaluate the improvement effectiveness of Seapolynol (Ecklonia cava extract) on postprandial glucose level in healthy subjects.

Not Applicable

Completed

• Conditions: Endocrine, nutritional and metabolic disease

• Registration Number: KCT0002206
• Lead Sponsor: Ewha Womans University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

1) Subject who voluntarily agree to participate and signs informed consent form
2) 20 years= Age <70 years (Ratio of men and women 1:1) 3) Fasting blood glucose><126mg>/dL
4) Subject who comply with dietary/exercise guidlines for intervention period

Exclusion Criteria

1) Continuous consumption of drug that affect glucose metabolism, inflammation, antioxidative capacity and lipid metabolism or dietary supplement or oriental medicine within 4 weeks before the first visit
2) Consumption of anticoagulant within 4 weeks before the first visit
3) BMI=18.5 or BMI=30
4) Following diseases :
? Diabetes, liver dysfunction, renal dysfunction, cardiovascular diseases (hypertension(= 140/90 mmHg), stroke, etc.), thyroid diseases
? Mental diseases such as depression, schizophrenia, alcoholism , drug addiction
? Wasting diseases such as malignant tumor etc., and severe muscular skeletal disease
? asthma and allergic diseases
5) Chronic smoker (= 20 cigarettes / day)
6) Excessive exercise (= 10 hours / week)
7) Subjects who controlling body weight or subjects who have changed of body weight more than 4kg within 4 weeks before the first visit
8) Recommended Food Score > 36
9) Subjects with hypersensitivity to test materials
10) Participation in other human study within 4 weeks before the first visit
11) Pregnant or lactating women
12) Any condition that the principal investigator believes may put the subjects at undue risk

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glucose, insulin etc

Secondary Outcome Measures

Name	Time	Method
Height, weight, BMI etc